Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats

Neuropsychopharmacology

Volumn 30, Issue 7, 2005, Pages 1312-1323

  O'Shea, Esther ^a   Escobedo, Isabel ^a   Orio, Laura ^a   Sanchez, Veronica ^a   Navarro, Miguel ^a   Green, A Richard ^b   Colado, M Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

5 HT; Dopamine; Locomotor activity; MDMA; Nucleus accumbens; Room and rectal temperature

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; MONOAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG ABUSE; ENVIRONMENTAL TEMPERATURE; HYPERTHERMIA; LOCOMOTION; MALE; MICRODIALYSIS; MONOAMINE RELEASE; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SEROTONIN RELEASE; TEMPERATURE SENSITIVITY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BODY TEMPERATURE; BRAIN CHEMISTRY; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; RATS; SEROTONIN; SEROTONIN AGENTS; TEMPERATURE; TIME FACTORS;

EID: 20544440847     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300673     Document Type: Article

References (57)

1. Baldwin HA, Williams JL, Snares M, Ferreira T, Cross AJ, Green AR (1994). Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br J Pharmacol 112: 188-194.
2. Beardsley PM, Balster RL, Harris LS (1986). Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend 18: 149-157.
3. Benloucif S, Galloway MP (1991). Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200: 1-8.
4. Benloucif S, Keegan MJ, Galloway MP (1993). Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 265: 373-377.
5. Bilsky EJ, Hubbell CL, Delconte JD, Reid LD (1991). MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids. Pharmacol Biochem Behav 40: 443-447.
6. Bilsky EJ, Reid LD (1991). MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol Biochem Behav 39: 509-512.
7. Boulenguez P, Rawlins JN, Chauveau J, Joseph MH, Mitchell SN, Gray JA (1996). Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacology 35: 1521-1529.
8. Broening HW, Bowyer JF, Slikker Jr W (1995). Age-dependent sensitivity of rats to the long term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethampheramine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275: 325-333.
9. Brown C, Osterloh J (1987). Multiple severe complications from recreational ingestion of MDMA ('Ecstasy'). J Am Med Assoc 258: 780-781.
10. Callaway CW, Wing LL, Geyer MA (1990). Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254: 456-464.
11. Chen JP, van Praag HM, Gardner EL (1991). Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543: 354-357.
12. Colado MI, O'Shea E, Granados R, Esteban B, Martín AB, Green AR (1999). Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4- methylenedioxymethamphetamine (MDMA or 'ecstasy') administration. Br J Pharmacol 126: 911-924.
13. Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE et al (2003). Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol 482: 339-341.
14. Crespi D, Mennini T, Gobbi M (1997). Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br J Pharmacol 121: 1735-1743.
15. Dafters RI (1995). Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') in rats. Psychopharmacology 114: 505-518.
16. Daniela E, Brennan K, Gittings D, Hely L, Schenk S (2004). Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77: 745-750.
17. De Deurwaerdere P, Spampinato U (1999). Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 73: 1033-1042.
18. Deutch AY, Cameron DS (1992). Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46: 49-56.
19. 3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse 9: 14-26.
20. Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001). 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154: 251-260.
21. Fibiger HC, Phillips AG (1974). Role of dopamine and norepinephrine in the chemistry of reward. J Psychiatr Res 11: 135-143.
22. Giacchino JL, Schertel ER, Horowitz JM, Horwitz BA (1983). Effect of p-chlorophenylalanine on thermoregulation in unrestrained rats. Am J Physiol 244: R299-R302.
23. Gold LH, Geyer MA, Koob GF (1989a). Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr 94: 101-126.
24. Gold LH, Hubner CB, Koob GF (1989b). A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology 99: 40-47.
25. Gold LH, Koob GF (1988). Methysergide potentiates the hyperactivity produced by MDMA in rats. Pharmacol Biochem Behav 29: 645-648.
26. Green AR, Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI (2004). Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology 173: 264-269.
27. Henry JA (1992). Ecstasy and the dance of death. BMJ 305: 5-6.
28. Henry JA, Jeffreys KJ, Dawling S (1992). Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy'). Lancet 340: 384-387.
29. Hubner CB, Bird M, Rassnick S, Kornetsky C (1988). The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology 95: 49-51.
30. Kalivas PW (1993). Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18: 75-113.
31. Kankaanpaa A, Meririnne E, Lillsunde P, Seppala T (1998). The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol Biochem Behav 59: 1003-1009.
32. Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996). Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15: 116-124.
33. Kelly PH, Seviour PW, Iversen SD (1975). Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94: 507-522.
34. König JFR, Klippel RA (1963). The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Robert E Krieger Publishing Co Inc.: New York.
35. Lamb RJ, Griffiths RR (1987). Self-injection of d,1-3,4- methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology 91: 268-272.
36. Lucas JJ, Segu L, Hen R (1997). 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol Pharmacol 51: 755-763.
37. Malberg JE, Seiden LS (1998). Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18: 5086-5094.
38. Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE (1996). Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol Biochem Behav 53: 99-105.
39. McCreary AC, Bankson MG, Cunningham KA (1999). Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/ 1D) receptors. J Pharmacol Exp Ther 290: 965-973.
40. Median AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002). The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135: 170-180.
41. 3H-GBR 12935. J Neural Transm Gen Sect 87: 1-14.
42. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37: 919-926.
43. Parsons LH, Justice Jr JB (1993). Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606: 195-199.
44. Frisco S, Pagannone S, Esposito E. (1994). Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271: 83-90.
45. Rudnick G, Wall SC (1992). The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci 89: 1817-1821.
46. Saadat KS, O'Shea E, Colado MI, Elliott JM, Green AR (2005). The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high temperature. Psychopharmacology (in press).
47. Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI (2001). The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br J Pharmacol 134: 46-57.
48. Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI, Green AR (2004). Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. J Psychopharmacol 18: 412-416.
49. Schechter MD (1991). Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination. Pharmacol Biochem Behav 38: 539-544.
50. Schenk S, Gittings D, Johnstone M, Daniela E (2003). Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169: 21-27.
51. Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL (1992). Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse. Lancet 339: 677-678.
52. Swerdlow NR, Koob GF (1985). Separate neural substrates of the locomotor activating-properties of amphetamine, heroin, caffeine and corticotrophin releasing factor (CRF) in the rat. Pharmacol Biochem Behav 23: 303-307.
53. Trifunovic RD, Brodie MS (1996). The effects of clomipramine on the excitatory action of ethanol on dopaminergic neurons of the ventral tegmental area in vitro. J Pharmacol Exp Ther 276: 34-40.
54. Vaccarino FJ, Amalric M, Swerdlow NR, Koob GF (1986). Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol Biochem Behav 24: 61-65.
55. White SR, Duffy P, Kalivas PW (1994). Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62: 41-50.
56. Wise RA, Bozarth MA (1982). Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav 17: 239-243.
57. Yamamoto BK, Spanos LJ (1988). The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148: 195-203.